Tissue pharmacokinetics and pharmacodynamics of AmBisome® (L-AmBis) in uninfected and infected animals and their effects on dosing regimens

MLA

Richard T. Proffitt, et al. “Tissue Pharmacokinetics and Pharmacodynamics of AmBisome® (L-AmBis) in Uninfected and Infected Animals and Their Effects on Dosing Regimens.” Journal of Liposome Research, vol. 27, no. 3, May 2017. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....025e0551272c5ad23492577f729263b6&authtype=sso&custid=ns315887.

APA

Richard T. Proffitt, Jill Adler-Moore, Jon A. Olson, & Gerard M. Jensen. (2017). Tissue pharmacokinetics and pharmacodynamics of AmBisome® (L-AmBis) in uninfected and infected animals and their effects on dosing regimens. Journal of Liposome Research, 27(3).

Chicago

Richard T. Proffitt, Jill Adler-Moore, Jon A. Olson, and Gerard M. Jensen. 2017. “Tissue Pharmacokinetics and Pharmacodynamics of AmBisome® (L-AmBis) in Uninfected and Infected Animals and Their Effects on Dosing Regimens.” Journal of Liposome Research 27 (3). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....025e0551272c5ad23492577f729263b6&authtype=sso&custid=ns315887.